Re: Questionable utility of Melan-A/Mart-1 immunoperoxidase staining while doing mohs surgery for melanoma [3]

Dermatologic Surgery

Volumn 31, Issue 4, 2005, Pages 495-

  Geisse, John K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MELAN A;

CANCER DIAGNOSIS; CELL COUNT; CHEMOSURGERY; FROZEN SECTION; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; LABORATORY DIAGNOSIS; LETTER; MELANOMA; PRIORITY JOURNAL;

EID: 16844387024     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2005.31126     Document Type: Letter

References (4)

1. Bricca GN, Brodland DG, Zitelli JA. Immunostaining melanoma frozen sections: the 1-hour protocol. J Dermatol Surg 2004;30:403-8.
2. Kelly LC, Starkus L. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1. J Am Acad Dermatol 2002;46:78-84.
3. Albertini JG, Elston DM, Libow LF, et al. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, a unique mapping technique. Dermatol Surg 2002;28:656-65.
4. El Shabrawi-Caelen L, Kerl H, Cerroni L. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis. Am J Dermatopathol 2004;26:364-6.